2004-04-01
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro
Publication
Publication
Journal of Clinical Endocrinology and Metabolism , Volume 89 - Issue 4 p. 1577- 1585
Additional Metadata | |
---|---|
doi.org/10.1210/jc.2003-031344, hdl.handle.net/1765/55379 | |
Journal of Clinical Endocrinology and Metabolism | |
Organisation | Department of Internal Medicine |
Hofland, L., van der Hoek, J., van Koetsveld, P., de Herder, W., Waaijers, M., Sprij-Mooij, D., … Lamberts, S. (2004). The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Journal of Clinical Endocrinology and Metabolism, 89(4), 1577–1585. doi:10.1210/jc.2003-031344 |